An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Fiji health authorities are scrambling to stem an outbreak of HIV, as growing meth use and alarming needle-sharing trends ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...